Key Financial Data Of Group

Oncolys BioPharma Inc. - Filing #7719656

Concept As at
2018-09-30
2018-07-01 to
2018-09-30
2018-01-01 to
2018-09-30
As at
2017-12-31
2017-01-01 to
2017-12-31
2017-07-01 to
2017-09-30
As at
2017-09-30
2017-01-01 to
2017-09-30
Key financial data of group
Business results of group
Net sales
118,422,000 JPY
229,139,000 JPY
29,027,000 JPY
Ordinary profit (loss)
-899,150,000 JPY
-1,087,185,000 JPY
-776,782,000 JPY
Net assets
2,856,896,000 JPY
2,931,893,000 JPY
3,165,334,000 JPY
Total assets
3,345,203,000 JPY
3,526,222,000 JPY
3,775,634,000 JPY
Basic earnings (loss) per share
-21.81
-79.31
-106.23
-24.18
-77.81
Diluted earnings per share
Equity-to-asset ratio
0.850 xbrli:pure
0.829 xbrli:pure
0.835 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.